Titre:
  • Trastuzumab-associated cardiac events at 8 years of median follow-up in the herceptin adjuvant trial (BIG 1-01)
Auteur:Azambuja, Evandro; Piccart-Gebhart, Martine; Procter, Marion; Agbor-Tarh, Dominique; Cameron, David A; Smith, Ian; Dowsett, Mitch; Van Veldhuisen, Dirk Jan; Metzger-Filho, Otto; Gelber, Richard; Steinseifer, Jutta; Suter, Thomas; Untch, Michael; Jackisch, Christian; Gianni, Luca; Baselga, José; Bell, Richard; Leyland-Jones, Brian
Informations sur la publication:Journal of clinical oncology, 32, 20, page (2159-2165)
Statut de publication:Publié, 2014-07
Sujet CREF:Cancérologie
MeSH keywords:Adult
Aged
Antibodies, Monoclonal, Humanized -- administration & dosage -- adverse effects
Antineoplastic Agents -- administration & dosage -- adverse effects
Breast Neoplasms -- chemistry -- drug therapy -- pathology -- surgery
Chemotherapy, Adjuvant
Drug Administration Schedule
Female
Follow-Up Studies
Heart Failure -- chemically induced
Humans
Incidence
Logistic Models
Mastectomy, Segmental
Middle Aged
Neoplasm Staging
Radiotherapy, Adjuvant
Receptor, ErbB-2 -- analysis
Tumor Markers, Biological -- analysis
Ventricular Function, Left -- drug effects
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2013.53.9288
info:pii/JCO.2013.53.9288
info:scp/84905858933
info:pmid/24912899